Jichao Y. Wu

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

MYDGF Governs Endothelial Homeostasis in Hypertension.

MYDGF Governs Endothelial Homeostasis in Hypertension.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: February 13, 2026

CYFIP2 deficiency ameliorates renal interstitial fibrosis through attenuating tubular senescence in hypertensive nephropathy.

CYFIP2 deficiency ameliorates renal interstitial fibrosis through attenuating tubular senescence in hypertensive nephropathy.

Journal: Acta pharmacologica Sinica

Published: November 21, 2025

IFI16 is essential to linking DNA damage and ferroptosis in acute kidney injury.

IFI16 is essential to linking DNA damage and ferroptosis in acute kidney injury.

Journal: Cell death & disease

Published: August 08, 2025

G-Protein-Coupled Receptors in Chronic Kidney Disease Induced by Hypertension and Diabetes.

G-Protein-Coupled Receptors in Chronic Kidney Disease Induced by Hypertension and Diabetes.

Journal: Cells

Published: March 30, 2025

Oxysterol Sensing Through GPR183 Triggers Endothelial Senescence in Hypertension.

Oxysterol Sensing Through GPR183 Triggers Endothelial Senescence in Hypertension.

Journal: Circulation research

Published: August 23, 2024

Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease.

Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease.

Journal: Cell stem cell

Published: June 24, 2024

Network pharmacology and experimental validation to investigate the mechanism of Nao-Ling-Su capsule in the treatment of ischemia/reperfusion-induced acute kidney injury.

Network pharmacology and experimental validation to investigate the mechanism of Nao-Ling-Su capsule in the treatment of ischemia/reperfusion-induced acute kidney injury.

Journal: Journal of ethnopharmacology

Published: December 18, 2023

Ceftazidime-avibactam induced renal disorders: past and present.

Ceftazidime-avibactam induced renal disorders: past and present.

Journal: Frontiers in pharmacology

Published: October 30, 2023

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.

Journal: Metabolism: clinical and experimental

Published: August 10, 2023

Targeting RNA oxidation by ISG20-mediated degradation is a potential therapeutic strategy for acute kidney injury.

Targeting RNA oxidation by ISG20-mediated degradation is a potential therapeutic strategy for acute kidney injury.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 17, 2023

HDAC9-mediated epithelial cell cycle arrest in G2/M contributes to kidney fibrosis in male mice.

HDAC9-mediated epithelial cell cycle arrest in G2/M contributes to kidney fibrosis in male mice.

Journal: Nature communications

Published: November 21, 2022

Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 17, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026